- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-mer
- Ligands
- 24 x CDL: CARDIOLIPIN(Non-covalent)
- 4 x LMT: DODECYL-BETA-D-MALTOSIDE(Non-covalent)
LMT.7: 11 residues within 4Å:- Chain D: Y.30, W.33, L.34, Y.37, N.38, Q.41, K.42
- Chain G: W.91, Y.93, I.103
- Ligands: CDL.4
2 PLIP interactions:1 interactions with chain D, 1 interactions with chain G- Hydrogen bonds: D:N.38
- Hydrophobic interactions: G:W.91
LMT.17: 9 residues within 4Å:- Chain G: K.31, G.32, W.35, W.36, F.39, V.43, L.111, L.115, R.119
2 PLIP interactions:2 interactions with chain G- Hydrophobic interactions: G:W.36
- Hydrogen bonds: G:W.36
LMT.29: 11 residues within 4Å:- Chain S: Y.30, W.33, L.34, Y.37, N.38, Q.41, K.42
- Chain V: W.91, Y.93, I.103
- Ligands: CDL.26
2 PLIP interactions:1 interactions with chain V, 1 interactions with chain S- Hydrophobic interactions: V:W.91
- Hydrogen bonds: S:N.38
LMT.39: 9 residues within 4Å:- Chain V: K.31, G.32, W.35, W.36, F.39, V.43, L.111, L.115, R.119
2 PLIP interactions:2 interactions with chain V- Hydrophobic interactions: V:W.36
- Hydrogen bonds: V:W.36
- 4 x Q7G: 2-{[(4-O-alpha-D-glucopyranosyl-alpha-D-glucopyranosyl)oxy]methyl}-4-{[(3beta,9beta,14beta,17beta,25R)-spirost-5-en-3-yl]oxy}butyl 4-O-alpha-D-glucopyranosyl-alpha-D-glucopyranoside(Non-covalent)
Q7G.8: 10 residues within 4Å:- Chain D: G.110, Y.111, I.113, P.114, F.115
- Chain N: W.47, W.51, Y.52
- Ligands: CDL.2, CDL.5
4 PLIP interactions:4 interactions with chain N- Hydrophobic interactions: N:W.47, N:W.51, N:Y.52, N:Y.52
Q7G.20: 15 residues within 4Å:- Chain A: F.4, F.6
- Chain B: Y.46
- Chain K: Y.124, M.129, P.130, L.138, S.139, G.140, P.141, H.144
- Chain N: A.26, L.27
- Ligands: CDL.1, CDL.21
4 PLIP interactions:3 interactions with chain K, 1 interactions with chain B- Hydrogen bonds: K:G.140, K:H.144
- Salt bridges: K:H.144
- Hydrophobic interactions: B:Y.46
Q7G.30: 10 residues within 4Å:- Chain 2: W.47, W.51, Y.52
- Chain S: G.110, Y.111, I.113, P.114, F.115
- Ligands: CDL.24, CDL.27
4 PLIP interactions:4 interactions with chain 2- Hydrophobic interactions: 2:W.47, 2:W.51, 2:Y.52, 2:Y.52
Q7G.42: 15 residues within 4Å:- Chain 2: A.26, L.27
- Chain P: F.4, F.6
- Chain Q: Y.46
- Chain Z: Y.124, M.129, P.130, L.138, S.139, G.140, P.141, H.144
- Ligands: CDL.23, CDL.43
4 PLIP interactions:1 interactions with chain Q, 3 interactions with chain Z- Hydrophobic interactions: Q:Y.46
- Hydrogen bonds: Z:G.140, Z:H.144
- Salt bridges: Z:H.144
- 4 x PEE: 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine(Non-covalent)
PEE.10: 8 residues within 4Å:- Chain D: W.5
- Chain E: V.2, L.3, F.4, S.5, S.10, L.12
- Chain F: R.10
2 PLIP interactions:1 interactions with chain F, 1 interactions with chain E- Salt bridges: F:R.10
- Hydrogen bonds: E:S.5
PEE.22: 25 residues within 4Å:- Chain A: F.173, Y.174, V.176, F.177, C.178
- Chain J: L.117, Y.144
- Chain O: P.35, M.38, I.39, N.42, A.43, R.44, L.46
- Chain X: V.26, Y.30, K.33
- Chain Y: L.117, G.118, Q.120
- Ligands: CDL.18, CDL.19, CDL.40, CDL.41, PEE.44
15 PLIP interactions:3 interactions with chain X, 5 interactions with chain A, 4 interactions with chain O, 2 interactions with chain Y, 1 interactions with chain J- Hydrophobic interactions: X:V.26, X:Y.30, A:F.173, A:F.173, A:Y.174, A:V.176, A:F.177, O:P.35, O:M.38, O:I.39, Y:L.117, Y:L.117, J:L.117
- Salt bridges: X:K.33
- Hydrogen bonds: O:L.46
PEE.32: 8 residues within 4Å:- Chain S: W.5
- Chain T: V.2, L.3, F.4, S.5, S.10, L.12
- Chain U: R.10
2 PLIP interactions:1 interactions with chain U, 1 interactions with chain T- Salt bridges: U:R.10
- Hydrogen bonds: T:S.5
PEE.44: 25 residues within 4Å:- Chain 3: P.35, M.38, I.39, N.42, A.43, R.44, L.46
- Chain I: V.26, Y.30, K.33
- Chain J: L.117, G.118, Q.120
- Chain P: F.173, Y.174, V.176, F.177, C.178
- Chain Y: L.117, Y.144
- Ligands: CDL.18, CDL.19, PEE.22, CDL.40, CDL.41
14 PLIP interactions:5 interactions with chain P, 3 interactions with chain 3, 3 interactions with chain I, 1 interactions with chain Y, 2 interactions with chain J- Hydrophobic interactions: P:F.173, P:F.173, P:Y.174, P:V.176, P:F.177, 3:P.35, 3:I.39, I:V.26, I:Y.30, Y:L.117, J:L.117, J:L.117
- Hydrogen bonds: 3:L.46
- Salt bridges: I:K.33
- 8 x PC1: 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
PC1.11: 25 residues within 4Å:- Chain E: R.64, W.65, D.68, H.69, D.107
- Chain J: I.98, L.101, L.104, T.105, V.108
- Chain M: I.75, L.83, W.86, C.90, I.93, Y.94, Q.95, Y.97, E.98
- Chain O: P.18, M.21, F.22, F.25, F.29, K.40
8 PLIP interactions:2 interactions with chain E, 2 interactions with chain O, 4 interactions with chain M- Salt bridges: E:D.68, E:H.69, M:E.98
- Hydrophobic interactions: O:F.25, O:F.25, M:W.86, M:I.93, M:Y.97
PC1.12: 41 residues within 4Å:- Chain A: L.12, L.15, L.16, Y.19, L.68, Y.69, L.71, I.72, L.73, Y.74, Y.166, Y.195, Y.199, L.203
- Chain E: F.33, A.44, L.45, P.46, L.51, Y.52, M.55, I.56, P.57, I.59, Y.60, F.61, R.64, L.111
- Chain M: L.29, V.30, F.31
- Chain O: M.1, L.2, F.23, S.26, V.27, F.29, W.30, E.33, Y.34, M.37
22 PLIP interactions:8 interactions with chain E, 8 interactions with chain O, 1 interactions with chain M, 5 interactions with chain A- Hydrophobic interactions: E:L.45, E:P.46, E:Y.52, E:M.55, E:I.56, E:I.56, E:P.57, E:Y.60, O:L.2, O:F.23, O:W.30, O:W.30, M:V.30, A:I.72
- Hydrogen bonds: O:W.30, O:Y.34, O:Y.34, A:L.73, A:Y.166, A:Y.199
- Salt bridges: O:E.33
- pi-Cation interactions: A:Y.166
PC1.13: 32 residues within 4Å:- Chain A: Y.83, F.86, C.87, F.90
- Chain B: T.34, L.37
- Chain F: F.32, T.33, I.35, F.36, L.37, K.39, H.40, M.41
- Chain H: T.85, W.86, A.89, V.90, Y.92, F.93, W.94
- Chain N: W.65, Y.66, R.69, S.70, L.73, F.74
- Ligands: CDL.3, CDL.5, CDL.6, CDL.15, CDL.21
15 PLIP interactions:4 interactions with chain H, 3 interactions with chain A, 7 interactions with chain F, 1 interactions with chain N- Hydrophobic interactions: H:W.86, H:W.86, A:Y.83, A:F.86, A:F.90, F:F.32, F:F.32, F:I.35, N:Y.66
- Hydrogen bonds: H:W.94, F:H.40
- pi-Cation interactions: H:W.94
- Salt bridges: F:K.39, F:K.39, F:H.40
PC1.16: 16 residues within 4Å:- Chain A: F.106, F.107
- Chain G: C.49, V.52, L.53, R.63, Q.64, Y.65, V.75, A.79, M.83
- Chain H: R.25, Y.70
- Ligands: CDL.3, CDL.14, CDL.15
3 PLIP interactions:3 interactions with chain G- Hydrophobic interactions: G:V.75
- Hydrogen bonds: G:Q.64
- Salt bridges: G:R.63
PC1.33: 25 residues within 4Å:- Chain 1: I.75, L.83, W.86, C.90, I.93, Y.94, Q.95, Y.97, E.98
- Chain 3: P.18, M.21, F.22, F.25, F.29, K.40
- Chain T: R.64, W.65, D.68, H.69, D.107
- Chain Y: I.98, L.101, L.104, T.105, V.108
8 PLIP interactions:4 interactions with chain 1, 2 interactions with chain T, 2 interactions with chain 3- Hydrophobic interactions: 1:W.86, 1:I.93, 1:Y.97, 3:F.25, 3:F.25
- Salt bridges: 1:E.98, T:D.68, T:H.69
PC1.34: 41 residues within 4Å:- Chain 1: L.29, V.30, F.31
- Chain 3: M.1, L.2, F.23, S.26, V.27, F.29, W.30, E.33, Y.34, M.37
- Chain P: L.12, L.15, L.16, Y.19, L.68, Y.69, L.71, I.72, L.73, Y.74, Y.166, Y.195, Y.199, L.203
- Chain T: F.33, A.44, L.45, P.46, L.51, Y.52, M.55, I.56, P.57, I.59, Y.60, F.61, R.64, L.111
22 PLIP interactions:8 interactions with chain T, 8 interactions with chain 3, 5 interactions with chain P, 1 interactions with chain 1- Hydrophobic interactions: T:L.45, T:P.46, T:Y.52, T:M.55, T:I.56, T:I.56, T:P.57, T:Y.60, 3:L.2, 3:F.23, 3:W.30, 3:W.30, P:I.72, 1:V.30
- Hydrogen bonds: 3:W.30, 3:Y.34, 3:Y.34, P:L.73, P:Y.166, P:Y.199
- Salt bridges: 3:E.33
- pi-Cation interactions: P:Y.166
PC1.35: 32 residues within 4Å:- Chain 2: W.65, Y.66, R.69, S.70, L.73, F.74
- Chain P: Y.83, F.86, C.87, F.90
- Chain Q: T.34, L.37
- Chain U: F.32, T.33, I.35, F.36, L.37, K.39, H.40, M.41
- Chain W: T.85, W.86, A.89, V.90, Y.92, F.93, W.94
- Ligands: CDL.25, CDL.27, CDL.28, CDL.37, CDL.43
15 PLIP interactions:3 interactions with chain P, 4 interactions with chain W, 7 interactions with chain U, 1 interactions with chain 2- Hydrophobic interactions: P:Y.83, P:F.86, P:F.90, W:W.86, W:W.86, U:F.32, U:F.32, U:I.35, 2:Y.66
- Hydrogen bonds: W:W.94, U:H.40
- pi-Cation interactions: W:W.94
- Salt bridges: U:K.39, U:K.39, U:H.40
PC1.38: 16 residues within 4Å:- Chain P: F.106, F.107
- Chain V: C.49, V.52, L.53, R.63, Q.64, Y.65, V.75, A.79, M.83
- Chain W: R.25, Y.70
- Ligands: CDL.25, CDL.36, CDL.37
3 PLIP interactions:3 interactions with chain V- Hydrophobic interactions: V:V.75
- Hydrogen bonds: V:Q.64
- Salt bridges: V:R.63
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Gahura, O. et al., An ancestral interaction module promotes oligomerization in divergent mitochondrial ATP synthases. Nat Commun (2022)
- Release Date
- 2022-10-26
- Peptides
- ATP synthase subunit a: AP
subunit-8: BQ
subunit-d: CR
ATPTB1: DS
subunit-f: ET
subunit-i/j: FU
ATPTB6: GV
subunit-k: HW
subunit-e: IX
subunit-g: JY
ATPTB11: KZ
ATPTB12: L0
subunit-b: M1
ATPEG3: N2
ATPEG4: O3 - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AP
aB
CQ
cC
DR
dD
ES
eE
FT
fF
IU
iG
JV
jH
KW
kI
LX
lJ
MY
mK
NZ
nL
O0
oM
P1
pN
Q2
qO
R3
r
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-mer
- Ligands
- 24 x CDL: CARDIOLIPIN(Non-covalent)
- 4 x LMT: DODECYL-BETA-D-MALTOSIDE(Non-covalent)
- 4 x Q7G: 2-{[(4-O-alpha-D-glucopyranosyl-alpha-D-glucopyranosyl)oxy]methyl}-4-{[(3beta,9beta,14beta,17beta,25R)-spirost-5-en-3-yl]oxy}butyl 4-O-alpha-D-glucopyranosyl-alpha-D-glucopyranoside(Non-covalent)
- 4 x PEE: 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine(Non-covalent)
- 8 x PC1: 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Gahura, O. et al., An ancestral interaction module promotes oligomerization in divergent mitochondrial ATP synthases. Nat Commun (2022)
- Release Date
- 2022-10-26
- Peptides
- ATP synthase subunit a: AP
subunit-8: BQ
subunit-d: CR
ATPTB1: DS
subunit-f: ET
subunit-i/j: FU
ATPTB6: GV
subunit-k: HW
subunit-e: IX
subunit-g: JY
ATPTB11: KZ
ATPTB12: L0
subunit-b: M1
ATPEG3: N2
ATPEG4: O3 - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AP
aB
CQ
cC
DR
dD
ES
eE
FT
fF
IU
iG
JV
jH
KW
kI
LX
lJ
MY
mK
NZ
nL
O0
oM
P1
pN
Q2
qO
R3
r